Ilaprazole 促销  ≥98%

促销价¥{{model.attbuying.price}}

市场价¥0.00

累计销量0 累计评价0 人评论

别称 {{model.alias}}
中文名称 {{model.name}}
英文名称 {{model.enname}}
品牌 {{model.brand}}
CAS {{model.cas}}
分子式
分子量 {{model.molecularweight}}
MDL {{model.mdl}}
货号 {{model.procode}}
数量

+ -

库存{{model.attbuying.number}}
包装规格:100mg 250mg 1g 5g in glass bottle
溶解性:溶于DMSO(≥35mg/ml)
产品描述:基本信息 产品编号: I10361  产品名称: Ilaprazole CAS: 172152-36-2   储存条件 粉末 -20℃ 四年     分子式: C19H18N4O2S 溶于液体 -80℃ 6个月 分子量: 366.44 -20℃ 1个月 化学名:  2-[(4-METHOXY-3-METHYL-PYRIDIN-2-YL)METHYLSULFINYL]-5-PYRROL-1-YL-3H-BENZOIMIDAZOLE Solubility (25°C):   体外:   DMSO 73mg/mL (199.21mM) Ethanol 14mg/mL (38.2mM) Water Insoluble 体内(现配现用):   <1mg/ml表示微溶或不溶。 普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。   制备储备液   浓度   溶液体积 质量   1mg   5mg   10mg 1mM 2.7290mL 13.6448mL 27.2896mL 5mM 0.5458mL 2.7290mL 5.4579mL 10mM 0.2729mL 1.3645mL 2.7290mL   生物活性 产品描述 一种具有口服活性质子泵抑制剂,以剂量依赖性方式不可逆地抑制H+/K+-ATPase,在兔壁细胞制剂中的IC50为6μM。Ilaprazole用于胃溃疡的研究。Ilaprazole也是一种有效的T细胞起源蛋白激酶(TOPK)抑制剂。 靶点 IC50:6.0μM (H+/K+-ATPase) 体外研究 On cumulation of 14C-aminopyrine in histamine stimulated parietal cells,the IC50 of Ilaprazole (IY-81149) sodium is 9nM. 体内研究 Ilaprazole (3-30mg/kg;i.d.) dose-dependently inhibits gastric acid secretion.In anesthetized rats,Ilaprazole dose-dependently increased gastric pH which was lowered by histamine infusion.In the case of i.v.injection,the ED50 of Ilaprazole and omeprazole is 1.2 and 1.4mg/kg and in the case of i.d.administration,the ED50 of Ilaprazole and omeprazole is 3.9 and 4.1mg/kg,respectively.Ilaprazole also significantly inhibits pentagastrin-stimulated gastric secretion.Its ED50 is 2.1mg/kg and that of Omeprazole is 3.5mg/kg with i.d.administration.In the case of i.v.injection,Ilaprazole is equipotent to Omeprazole.Ilaprazole also inhibits gastric acid secretion strongly in fistular rats.The ED50 of Ilaprazole administered intraduodenally is 0.43mg/kg and that of Omeprazole is 0.68mg/kg. Animal Model: Male SD rat (after pylorus ligation) Dosage: 3,10,30mg/kg Administration: Intraduodenally Result: The acid output and volume significantly inhibited by about 60% and 46% at 3mg/kg were s,respectively.At 30mg/kg,it showed 93% and 73% inhibition on acid output and volume,respectively.
保存条件:-20℃